|
|  |
|
NPA's aim is to: identify and define the human and financial costs of drug-related problems in patients with kidney disease, and to develop solutions to those problems; become the foremost provider of medication-related education to patients, pre-dialysis, dialysis, and transplant providers, and to commercial and public payers and policy makers.
|
|
|
|
